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Value of Ultrasound in Rheumatologic Diseases
The use of musculoskeletal ultrasound in rheumatology clinical practice has rapidly 
increased over the past decade. Ultrasound has enabled rheumatologists to diagnose, 
prognosticate and monitor disease outcome. Although international standardization 
remains a concern still, the use of ultrasound in rheumatology is expected to grow further 
as costs fall and the opportunity to train in the technique improves. We present a review of 
value of ultrasound, focusing on major applications of ultrasound in rheumatologic 
diseases.
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INTRODUCTION
The use of musculoskeletal ultrasound in rheumatology has in-
creased dramatically over the past decade both as a result of 
technological developments and a desire to identify and treat 
inflammation early. High quality ultrasound machines with 
good spatial resolution have provided rheumatologists with a 
means of identifying inflammation and structural damage, mon-
itoring disease and predicting therapeutic responses. Ultrasound 
has clear advantages over other imaging tools such as magnetic 
resonance imaging (MRI) in terms of better tolerability, an abil-
ity to scan multiple joints at one sitting and its ability to directly 
correlate clinical and imaging findings. Furthermore high reso-
lution gray scale images combined with Doppler technique 
have made it possible to detect slow low volume blood flow, 
opening new avenues for detecting and grading inflammation 
in joints. Based on these developments and increasing interest, 
a special Ultrasound Task Force on behalf of Outcome Measures 
in Rheumatology Clinical Trial (OMERACT) organization was 
formed to develop standardized ways of acquiring images in 
addition to defining and scoring pathologies relevant to rheu-
matologists (1). This has provided a framework for collaborative 
studies on ultrasound assessment and measurement issues. In 
this review, we focus on major values of ultrasound in rheuma-
tologic diseases.
BRIEF DEVELOPMENTAL HISTORY OF 
ULTRASOUND IN RHEUMATOLOGY
After the discovery of the piezo-electric effect in crystals by the 
Pierre and Curie brothers in 1880, further research and devel-
opment in piezo-electricity followed. In particular, after the Ti-
tanic sank on its maiden voyage in 1912, scientists spurred on 
the development of how to detect submerged objects. The threat 
of German submarines to Allied shipping in World War I stimu-
lated more research into the development of ultrasound devic-
es (2). The first recorded detection and subsequent sinking of a 
submarine using an ultrasound device (called a hydrophone at 
that time) occurred in the Atlantic in 1916 during World War I. 
The military use of ultrasound lead to the development of med-
ical diagnostic ultrasound. Of note during World War II, rapid 
developments and refinements in military RADAR (Radio De-
tection and Ranging which used electromagnetic waves rather 
than ultrasound) was the precursor for subsequent medical ul-
trasound devices. In 1942, the Austrian neurologist-psychiatrist 
Karl Theodore Dussik was generally regarded as the first physi-
cian to use ultrasound for medical diagnosis (3). He attempted 
to locate brain tumors by measuring the transmission of an ul-
trasound beam through the skull. Later in 1956, Ian Donald 
from Scotland and Thomas Graham Brown from Glas gow made 
the world’s first two dimensional contact scanner where the 
transducer can be moved manually over the patient’s abdomen 
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with a resultant 2-D image reproduced on an oscilloscope. This 
brought the capability of ultrasound to a wider audience which 
in turn stimulated its further growth.
 The first report pertaining to musculoskeletal tissue was in 
1958 by Karl Theodore Dussik; titled “Measurement of articular 
tissue with ultrasound” and published in the American Journal 
of Physical Medicine. In this ex-vivo study, the attenuation of 
ultrasound during its propagation through human articular 
cartilage was first measured. Since this study was not related 
directly to clinical imaging, the study of “Ultrasound B-Scan-
ning in the differentiating of Baker’s Cyst and Thrombophlebi-
tis” in vivo in 1972 by Daniel McDonald and George Leopold is 
widely regarded as the first publication of clinically relevant 
musculoskeletal ultrasound (4). They described the use of a 
contact B-mode scanner to differentiate Backer’s cysts from 
thrombophlebitis. In 1969, Nicolaas Bom from the Netherlands 
developed the real-time multi-element linear array scanner 
which evolved into the very sophisticated real-time scanners 
that are widely available today in musculoskeletal ultrasound. 
ULTRASOUND IN RHEUMATOLOGY 
Rheumatoid arthritis
Synovitis
Since the first gray scale ultrasound demonstration of synovitis 
of knee joint in rheumatoid arthritis (5), numerous studies have 
demonstrated the clinical utility of ultrasound in evaluating flu-
id, synovial hypertrophy in inflammatory arthritis (6, 7). This 
was largely due to the fact that synovitis is the fundamental pa-
thology which is seen in all types of inflammatory arthritis. Gray 
scale ultrasound can depict a range of abnormalities from the 
minimally thickened synovium to severe hypertrophy with flu-
id, debris and villi (Fig. 1A). Ultrasound has shown its superior-
ity over clinical examination in the detection and assessment of 
synovitis, drawing the most attention and support with regard 
to the clinical use of ultrasound in rheumatology (8). Further-
more, with the administration of microbubbles contrast agents 
to increase backscattering, the sensitivity for the detection of a 
thickened, hypervascular synovium can be increased, and bet-
ter quantification of degree of inflammation can be achieved (9, 
10). With regard to scoring of gray scale synovitis used in stud-
ies, different scoring systems have been used, ranging from bi-
nary (yes/no) to semiquantitative 4-point (0-3) grading (11, 12). 
 Assessment of synovial activity expressed by increased vas-
cularity is extremely important to the diagnosis and evaluation 
of treatment effect. Traditionally, visualization of synovial in-
flammation has mainly been dominated by MRI. Recently, Dop-
pler ultrasound has been preferred to MRI in clinical practice, 
since Doppler mode allows the visualization of microvasculari-
ty within joint cavity and periarticular tissue. Doppler can pro-
vide useful clinical information regarding the presence or ab-
sence of flow through the joint (Fig. 2), which correlates with 
ongoing disease activities. The microvascular activity detected 
by Doppler ultrasound correlated well with histology specimen 
in knee and hip joint (13, 14). Moreover, intra-observer and in-
ter-observer reliability of still image interpretation is high for 
gray scale and Doppler (15). Several studies used Doppler for 
follow-up assessment after the treatment of corticosteroids and 
tumor necrosis factor antagonists (9, 16, 17), showing Doppler 
able to detect changes in synovial perfusion. In these studies, 
the power or colour Doppler signal was determined semi-quan-
titatively graded on a 0-3 scale (17, 18) or qualitatively. 
 A semiquantitative grading system in which vascularity is 
scored from 0 to 3 according to number or areas of vessel sig-
nals are widely used in clinical practice (19-21). However, the 
semi-quantitative scales are not a precise method of vascularity 
measurement and can be prone to intra-observer and inter-ob-
server variation. Alternatively, a quantitative scale quantified by 
measuring the Doppler colour pixels in the region of interest 
have also been used to measure inflammatory activity. Sono-
graphically measured disease activity was quantified by count-
ing colour pixels of region of interest using different vascularity 
analysis computer softwares (16, 22, 23), colour fraction defined 
as the fraction of colour pixels in a region of interest (24) and 
the area under the time–intensity curve with intravenous ultra-
sound contrast agent (9). However, the sensitivity of Doppler 
can be varied according to Doppler variables set by the ultraso-
nographer, as well as ultrasound units from different manufac-
turers (25). The lack of consensus make Doppler difficult to ap-
ply in routine clinical practice for assessment of disease activity, 
thus there needs to be further agreement on classifying the vas-
cularity.
 With regard to Doppler modalities, both colour and power 
Doppler have been used. Power Doppler displays the total back 
scattered energy mainly from red blood cells instead of mean 
Doppler shift used in colour Doppler. Power Doppler does not 
measure blood velocity or direction but is more sensitive to de-
tect microvascular low-velocity flow. Moreover, power Doppler 
is less angle dependent compared to colour Doppler and tech-
nologically does not aliase (26). Owing to these theoretical ad-
vantages, power Doppler has been better suited for assessing 
musculoskeletal diseases in rheumatology. However, these ad-
vantages of power Doppler have been disappearing in the new-
er high-end machines where the trend is that colour Doppler 
now is more sensitive than power Doppler (25). 
Tendinopathies
Tendons are also frequently involved in a wide range of inflam-
matory and non-inflammatory rheumatic diseases. Ultrasound 
is one of the best imaging modalities for assessing tendons due 
to its high image resolution. When diseased, tendons may be-
come hypoechogenic with loss of a fibrillar pattern, thicker, have 
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internal Doppler signals and a thickened surrounding tendon 
sheath which may exhibit Doppler (Fig. 1B). Tendon itself can 
show loss of fine fibrillar echotexture, focal thickening and hy-
poechoic (27). Ultrasound has been reported to be more sensi-
tive than MRI for the detection of tenosynovitis (28). However, 
in a study by Wakefield et al, the sensitivity and specificity of ul-
trasound were reported 0.15-0.44, and 0.98-0.99 respectively for 
tenosynovitis in finger joints of patients with early untreated 
Fig. 1. Ultrasound images of joints and peri-articular tissue showing typical signs of common rheumatologic diseases. (A) Longitudinal dorsal scan of the tibiotalar joint. A large 
ankle joint effusion with synovial proliferation (arrows) is seen. (B) Transverse and longitudinal scan of 3rd extensor tendon at dorsum of metacarpophalangeal joint showing 
tendinopathy represented as swelling of tendon sheath (arrow) in both plane. (C) In the transverse anterior scan of shoulder at 90° internal rotation, bony erosion (arrow) is seen. 
(D) MSD crystals are deposited within tendon sheath, causing tenosynovitis of extensor tendons. The high sparkling reflectivity of MSD crystals can make it easier to be detect-
ed and can be differentiated from synovial proliferation. (E) The sonographic double contour sign (arrow) is seen by the deposition of MSD crystals in the cartilage surface layers 
of knee joint. It is also characterized by angle independency (not demonstrated). (F) Achilles tendon near calcaneal insertion shows focal increased thickness and loss of fibrillar 
structures (arrow). 
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rheumatoid arhtritis using MRI as the gold standard (29). This 
lower value may be related to the lack of standardization of def-
inition of tenosynovitis at that time, which was developed later 
by OMERACT. 
 Ultrasound combined with power Doppler has been used to 
investigate the cause of shoulder pain in patients with rheuma-
toid arthritis. Ultrasound can help to differentiate glenohumeral 
synovitis with subdeltoid bursitis, tenosynovitis of biceps ten-
don as the cause of rheumatoid shoulder (30). A study showed 
overall good agreement between ultrasound and MRI with re-
gard to synovitis, erosion and bursitis and cuff tear of shoulder 
joint in patients with rheumatoid arthritis (31). Ultrasound can 
also be used to assess non-inflammatory cause of shoulder 
pain. Through a recent meta-analysis study with sixty-two stud-
ies assessing 6066 shoulders, it was concluded that ultrasound 
can be regarded as an appropriate technique for the assessment 
of rotator cuff tears with an acceptable sensitivity and specifici-
ty (32). In the elbow, both lateral and medial epicondylitis are 
due to an overuse injury from repetitive movement of the fore-
arm and the wrist resulting in stressing of the common extensor 
or flexor tendons. Ultrasound is also informative and accurate 
for the detection of clinical lateral and medial epicondylitis (33, 
34). These results can provide convincing evidence of capability 
of ultrasound in depicting mechanical tendon diseases as well 
as inflammatory causes in rheumatology clinical practice. Al-
though MRI can also detect low grade tendinopathies, the over-
all advantages of repeatability, non-invasiveness, wide availabil-
ity and ability to examine the tendon dynamically have made 
ultrasound more valuable tool for detecting tendon diseases. 
Thus ultrasound should be regarded as the first imaging mo-
dality for tendon involvement in rheumatologic diseases. 
Bone Erosions
Radiographically detected bone erosion is an important diag-
nostic criterion for rheumatoid arthritis (35) and its presence 
implies poor functional outcome. However, plain radiography 
can show only the erosions which are tangential to the X-ray 
beam direction. In contrast, ultrasound can visualize circum-
ferentially around the bone, which makes it possible to detect 
more erosions than simple radiography where erosions may be 
lost in the two dimensional projection (Fig. 1C). The first large 
study demonstrating the superiority of ultrasound over radiog-
raphy was reported in 2000 (36), showing its ability to detect 6.5 
fold more erosions than radiography in early rheumatoid ar-
thritis patients as well as 3.4 fold in late disease. With MRI con-
sidered the reference method, ultrasound has a slightly lower 
sensitivity than MRI but similar accuracy for detecting erosions 
(37, 38). With regard to scoring of erosions, although scoring 
system based on size (36) and semiquantitative scores (39) 
have been suggested, no consensus has been made in stan-
dardized scoring system. A wide variety of sizes and locations 
within joints with sometimes inaccessible acoustic window 
have made it difficult to standardize. In addition, erosions may 
be difficult to detect in the context of concomitant osteoarthritis.
Osteoarthritis
Osteoarthritis is traditionally evaluated by conventional radiog-
raphy in spite of the fact that radiography cannot depict articu-
lar cartilage. Ultrasound can overcome this barrier since it can 
visualize articular hyaline cartilage as a well defined anechoic 
band lacking internal echoes (40). Ultrasound can also show 
pathologic signs of articular cartilage in terms of thickness, trans-
parency, sharpness and related osteophytes. Nevertheless, ul-
trasound for the assessment of osteoarthritis seems to have rel-
atively less been focused on compared to rheumatoid arthritis. 
Recently, interest in the application of ultrasound in early and 
late osteoarthritis is emerging (40, 41).
 The first ultrasound study of cartilage in rheumatology dates 
back to 1992, where Iagnocco et al. reported diminished knee 
cartilage thickness, which is the hallmark of osteoarthritis, in 
Fig. 2. Assessment of inflammatory activity can be achieved with power Doppler. (A, B) These are two longitudinal dorsal views through the wrist joint. Both show moderate lev-
els of gray scale and power Doppler abnormalities consistent with active joint disease. 
A BWrist joint Wrist joint
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osteoarthritis patients, suggesting ultrasound as a useful non-
invasive method to study articular cartilage (42). Then, several 
studies investigated ultrasonographic cartilage abnormalities, 
reporting loss of sharp contour and clarity with increased echo-
genecity in joints involved by osteoarthritis (43, 44). MRI can 
show precise cartilage loss more sensitively than radiography 
and can also provide distinct advantages over radiography for 
joint space narrowing and its location (45). However, its use for 
the assessment of osteoarthritis has been limited due to high 
cost and accessibility in clinical practice. Thus, ultrasound has 
been focused on as an alternative valid non-invasive reproduc-
ible imaging modality to detect and quantify cartilage damage 
in osteoarthritis. Reflecting these interests, it was reported that 
insonation angle and sound speed in cartilage should be taken 
into account for accurate thickness measure (46). 
 There has been increasing evidence that synovitis plays a sig-
nificant role as a contributor in the disease pathogenesis (47). 
In osteoarthritic joints, synovitis with similar findings to rheu-
matoid arthritis has been shown (44), supporting major roles of 
synovitis in the pathogenesis of osteoarthritis. 
 Osteophytes appearing as elevated small step-up bony frag-
ment seen in two perpendicular planes close to joint space can 
be detected by ultrasound (Fig. 3). Depending on its interposi-
tion, it may be difficult to differentiate from bony erosions and 
normal cortical irregularity. Ultrasound can detect more osteo-
phytes compared with conventional radiography osteoarthritis 
of hand (48). In erosive osteoarthritis of hands, ultrasound also 
found more osteophytes than the radiography although X-ray 
may be better to detect the centrally placed erosions where the 
acoustic window is poor (49). Several studies have introduced 
semiquantitative scoring systems for osteoarthritis in the knee, 
hand and hip joint (40, 50, 51), though no consensus has been 
reached. Efforts in order to validate scoring systems are being 
undertaken by the OMERACT Ultrasound Task Force (52).
Crystal deposit diseases 
Crystal deposit diseases are a group of disorders characterized 
by the intra and extra-articular deposition of crystals. Mo noso-
dium urate (MSU) crystals as a consequence of raised serum 
uric acid level and calcium pyrophosphate dihydrate (CPPD) 
crystals are the most common forms. Ultrasound has become a 
useful diagnostic tool for gout and pseudogout. The highly spar-
kling reflectivity of MSU (Fig. 1D) and CPPD crystals can be 
easily detected with even minimal aggregates within cartilage 
and tendon sheaths. Once these crystals are deposited in the 
cartilage, the reflectivity of the cartilage is no longer dependent 
on the insonation angle of ultrasound beam (53). 
 The existence of a hyperechoic band over anechoic hyaline 
cartilage surface described as a double contour sign are seen in 
about 92% of gouty joints (Fig. 1E) (54). It has also been demon-
strated recently that the sonographic double contour signs of 
deposition of MSU crystals can be reversed completely on fol-
low-up if sustained normouricemia was achieved (55). In a pi-
lot study in patients with asymptomatic hyperuricemia, the 
presence of a double contour sign or hyperechoic cloud area 
was predictive of the detection of MSU crystals (56). Moreover, 
ultrasound can help distinguish tophi and other subcutaneous 
nodules including rheumatoid nodules and lipoma. A tophus, 
which is composed of MSU crystals, is most often seen as a het-
erogeneous mass often with intermittent hyperechoic foci com-
pared with rheumatoid nodules which are likely to be more ho-
mogeneous (57). In CPPD disease, the hyperechoic aggregates 
are likely to form a band within articular cartilage, which is the 
distinct ultrasound feature differentiating MSU crystals (53). 
The dense deposit of CPPD crystals ranging from punctate to 
large linear deposits can generate acoustic shadowing (58).
Spondyloarthropathies
The use of ultrasound in spondyloarthropathy is mainly for the 
detection of enthesitis such as Achilles tendonitis and plantar 
Fig. 3. Osteophyte usually appears as elevated small bony prominence (arrow) at the end of normal bone contour, close to joint space (A). It usually does not show Doppler sig-
nal (B). 
A B
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fasciitis. The other indication is for the detection of peripheral 
joint arthritis, similar to rheumatoid arthritis (59). Affected en-
theseal sites show signs of gray scale abnormality characterized 
by loss of normal fibrillar structures with an increased thick-
ness or intra-tendinal focal changes with or without Dopper 
signals (Fig. 1F). In a large scale study for peripheral enthesitis 
in patients with spondyloarthropathies, greater sensitivity for 
the detection of enthesitis over clinical examination was re-
ported (60). Power Doppler can also display the degree of se-
verity of enthesial involvement. In contrast, the role of MRI in 
the assessment of spondyloarthropathies has mainly been con-
fined to assess axial involvement since MRI lacks sensitivity 
and specificity for peripheral enthesitis. 
 Different scoring systems have also been suggested for en-
thesisitis. Each assesses different sites and different scoring sys-
tems. The earlier ones are only gray scale with the more recent 
ones involving Doppler. The first of these reported in 2006 was 
the Glasgow Ultrasound Enthesitis Scoring System (GUESS) 
which assesses five entheses of lower limb with gray-scale find-
ings (61). Another scoring system SEI (Sonographic Enthesitis 
Index) also uses gray scale findings but assess different enthe-
seal sites (62). A more recent Madrid Sonographic Enthesis In-
dex (MASEI) scoring system combined gray scale abnormali-
ties and Doppler activity. However, a recent systematic litera-
ture review by the OMERACT Ultrasound Task Force concluded 
that there remains a lack of consensus of how to define and score 
enthesitis. One important remit is to develop a score which sep-
arates inflammation from damage. This is a priority area cur-
rently under review by the OMERACT group (63).
Ultrasound guided interventions
Diagnostic and therapeutic musculoskeletal interventions in 
rheumatology include a wide range of procedures such as aspi-
ration of fluid from joints, bursa, tendon sheath and cystic le-
sions for diagnostic and therapeutic purpose as well as steroid 
injections into joint cavities and soft tissues. Real time visualiza-
tion of the needle and injected steroid by ultrasound enables 
the reliable placement of the needle tip in the joint cavity, bursa, 
tendon sheaths and intra-tendon (Fig. 4) (64). However, some 
studies reported no significant difference in accuracy between 
the blind and ultrasound-guided method (65, 66), although 
these results are studies of the larger joints such as knee and 
shoulder. In the relatively small interphalangeal joints and diffi-
cult joints to be accessed due to complex anatomy such as wrist 
and ankle, accurate needle positioning can be a particular chal-
lenge (67). In these joints, sonographic needle guidance have 
demonstrated improved accuracy and better clinical outcomes 
com pared with conventional palpation-guided blind methods 
(68, 69). Furthermore, Doppler can help the precise placement 
of the needle tip into the most inflamed intra-region, making 
the overall clinical outcomes better. A recent systematic review 
compared the accuracy of ultrasound-guided intra-articular in-
jections with blind injections using palpation or anatomic land-
marks, and confirmed that ultrasound-guidance raised the ac-
curacy of injections independent of anatomic site (70). 
Vasculitis
Vasculitis is an autoimmune disease characterized by the in-
flammation of the vessel wall. The lumen of large arteries can 
be measured and information about vessel wall, pulsatility and 
blood flow characteristics can be obtained using duplex mode. 
In rheumatology, the first ultrasound report for the diagnosis of 
arteritis was for giant cell (temporal) arteritis in 1995 (71). Since 
then, giant cell arteritis has drawn the most interest in arterits 
in rheumatology (71, 72). Affected temporal arteries showed 
edema, stenosis or occlusion characterized by a hypoechoic 
halo around a narrowed lumen due to edema of arterial wall, 
which may make possible the diagnosis of temporal arteritis 
without performing a temporal-artery biopsy (73). 
 Since then, the scope of vasculitis evaluated with ultrasound 
Fig. 4. Ultrasound guided intra-articular injection of 3rd proximal interphalageal joint of hand. (A) The tip and shaft of metallic needle (arrows) can be easily identified. (B) The 
crystalline steroid suspension can be observed on the screen as fine hyperechoic clouds or spots (arrow), which can increase the accuracy of injection. 
A B3rd proximal interphalangeal joint 3rd proximal interphalangeal joint
Proximal phalanx Proximal phalanxDistal phalanx Distal phalanx
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in rheumatology has expanded to Wegener’s granulomatosis 
(74), finger arteritis in systemic sclerosis (75) and Raynaud’s 
phenomenon (76), in which ultrasound showed superiority to 
visualize the narrowed lumen with thicken arterial wall. High 
resolution ultrasound may aid to differentiate primary and sec-
ondary Raynaud’s phenomenon by depicting the vessels as an-
giography. At present, ultrasound for the assessment of arteritis 
is expected to be a valuable tool for diagnostic workup and mon-
itoring in rheumatology.
Sjögren syndrome/salivary glands
The normal ultrasound echogenicity of major salivary glands is 
homogeneous. As affected glands gradually become fibrotic, 
the parenchyma becomes inhomogeneous with multiple scat-
tered small oval hypoechoic or anechoic areas with flow ob-
served within the glands in Doppler (Fig. 5) (77, 78). These find-
ings appear to have a high sensitivity and specificity for primary 
Sjögren syndrome (79). Ultrasound findings of parotid glands 
correlated well with MRI, showing a similar diagnostic accura-
cy compared to MRI (80) and sialography (81). Moreover, addi-
tional vascularity information in the glands obtained by spec-
tral Doppler in terms of resistive index and pulsatility index can 
be helpful for the diagnosis of Sjögren syndrome (82). However, 
inconsistent ultrasonographic diagnostic sensitivity ranging 
43%-93% and specificity ranging 64%-100% for Sjögren syn-
drome have been reported (81, 83, 84). These inconsistencies 
could be caused by lack of ultrasonographic classification crite-
ria for Sjögren syndrome. Moreover, a different ultrasonograph-
ic scoring system based on morphologic changes observed in 
gray scale ultrasound has been suggested for primary Sjögren 
syndrome (79, 85). Despite these flaws, the overall diagnostic 
accuracy of an ultrasound scoring system for primary Sjögren 
syndrome was comparable to salivary scintigraphy and salivary 
gland biopsy (81). Since ultrasound can demonstrate valuable 
objective evidence of glandular involvement of Sjögren syn-
drome, it is regarded as an emerging imaging method of first 
choice in patients suspected of having sicca syndrome (86). 
 Sjögren syndrome is frequently associated with a variety of B 
cell lymphomas and other lymphoproliferative disorders (87). 
Sometimes the differential diagnosis of ultrasonographic find-
ings can be challenging, thus meticulous studies should be un-
dertaken if concomitant lymphoma cannot be ruled out as well 
as the appreciation that ultrasound cannot always exclude more 
severe pathologies in which case other imaging may be employ-
ed (88). 
Inflammatory muscle diseases
Skeletal muscles appears relatively hypoechogenic under nor-
mal circumstances in contrast to echogenic fibroadipose septa 
and fascia. In rheumatology, idiopathic inflammatory muscle 
diseases including polymyositis, dermatomyositis and inclu-
sion body myositis can affect skeletal muscles focally and dif-
fusely. On ultrasound, affected muscle can show thickening 
and areas of hypoechogenicity different to the normal surroun-
ding muscle. Increased Doppler activity within the affected 
muscles can be observed. Ultrasound-guided closed muscle 
biopsy can also provide a minimally invasive approach for the 
diagnosis of focal myositis (89). However, the role of ultrasound 
in the assessment of inflammatory muscle diseases in rheuma-
tology have not yet been fully identified.
Limitations of ultrasound in rheumatology
The use of ultrasound in rheumatological diseases may be lim-
ited by several factors. The ultrasound beam cannot penetrate 
bone, making it impossible to visualize intraosseous changes 
such as bone marrow edema. Additionally, the ultrasound beam 
is attenuated (absorbed, refracted, diffracted or lost as heat) the 
deeper into tissue it goes and so images are less clear when in-
terrogating deeper structures even when low frequency probes 
are used. Moreover, joints with a limited acoustic window due 
to anatomical restriction such as the hip, and wrist may have a 
lower sensitivity to detect erosions and involvement of synovial 
pathologies. Although high intra-observer and inter-observer 
reliability have been reported (31, 90, 91), the detection of ultra-
sonographic abnormalities depends on the individual operator. 
However the studies from the OME RACT group have demon-
strated that with standardization, operator dependency can be 
diminished. To become an expert, plenty of clinical experience 
and a long period of training is needed. EULAR (European Lea-
gue Against Rheumatism) and the ACR (American College of 
Rheumatology) are currently setting out curricula and standard 
operating procedures for the acquisition and reading of ultra-
sound images.
Future perspectives
Three dimensional (3D) ultrasound provides an interesting as-
pect for the volumetric assessment of tissue blocks and quanti-
fication of region of interests. The saved images can be viewed 
Fig. 5. Transverse view of the parotid gland in a patient with primary Sjögren syn-
drome. Affected glands can show parenchymal inhomogenecity with multiple oval 
shaped small hypoechoic changes (courtesy of Sandrine Jousse-Joulin). 
Dist 4.68 cm
Dist 1.38 cm
Surf 4.99 cm2
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in sagittal, coronal and axial planes and relatively operator in-
dependent compared to two dimensional (2D) ultrasound im-
aging. The 3D images had a good correlation with 2D images 
for detection of synovitis and bone erosion (92) and was able to 
delineate the shape of the synovium in the knee joint (93). The 
use of 3D ultrasound currently remains mainly in the research 
area due to relatively low image quality and additional cost. 
 Sonoelastography measures the strain of the tissues by ana-
lyzing ultrasound echo signals while the probe compresses or 
relaxes the tissue (94). The compression wave may be generat-
ed by the operator (compression elastography) or by the probe 
(shear wave elastography). In rheumatology, sonoelastography 
has shown promising results in detecting changes in Achilles 
tendons (95) (Fig. 6), and elbow ligaments (96) and has allowed 
the differentiation between rheumatoid nodules and gout to-
phi (97). In systemic sclerosis patients, sonoelastography can 
demonstrate reduction of strain caused by loss of elasticity in 
the dermis (98). Since sonoelastography has started to be ap-
plied in rheumatologic diseases recently, more comprehensive 
and extended studies are needed to establish the contribution 
of sonoelastography in rheumatologic diseases. 
 Another interesting advance is known as fusion imaging. Here 
the ultrasound image is fused with MRI or Computed Tomog-
raphy (CT) image to combine the advantages of real time image 
acquisition by ultrasound with better depiction of bone and 
soft tissue lesions. This technique can be used to improve injec-
tion accuracy of joints with difficult access such as sacroiliac 
joint (99). However, the usefulness of fusion imaging in rheu-
matology should be decided in the future since there is lack of 
clinical research data. 
CONCLUSION
Ultrasound is becoming an essential tool in the management of 
rheumatology patients through its gradual incorporation into 
routine clinical use in many countries and rheumatology cen-
ters. Evidence for the reliability, validity as well as clinical value 
of ultrasound is increasing with continuing studies of this mo-
dality. Future development in technology together with con-
sensus of international and national educational programs will 
spur the wider application of ultrasound for various rheumato-
logic diseases, enabling it to become a powerful imaging tool 
for rheumatologists. 
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